Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Sales of Pepsin to Increase at 4.7% CAGR as Applications across Pharmaceutical Industry Surges

This image opens in the lightbox

News provided by

Fact.MR

29 Nov, 2021, 12:07 GMT

Share this article

Share toX

Share this article

Share toX

- Pepsin Powder to Account for More than 69% of the Overall Pepsin Demand in 2021

- The latest study by Fact.MR conducted on the pepsin market offers comprehensive insights into key factors driving growth through 2031. It offers in-depth analysis based on segments in terms of product form, end use sector, and grade type. The report offers detailed analysis of the scope for expansion in developed and developing markets through 2021.

NEW YORK, Nov. 29, 2021 /PRNewswire/ -- As per thorough research conducted by Fact.MR, the global pepsin market is set to total US$ 3 Bn in 2021. Increasing use of pepsin in the industrial sector to remove unwanted remaining tissues from partially processed hide in leather is expected to propel the demand in the market. In response to this, the pepsin market is projected to total US$ 4.8 Bn through 2031.

Demand for pepsin is rapidly increasing across the pharmaceutical industry. Pepsin, being an endopeptidase, is extensively being used in the replacement therapy for the treatment of disorders such as indigestion, chronic pancreatitis, and cystic fibrosis to increase the production of digestive enzymes.

Hence, increasing prevalence of aforementioned diseases across the world is expected to drive the sales at a CAGR of 4.7% during the forecast period 2021-2031.

Further, pepsin is finding a wide range of applications including across the food & beverages industry for food processing, meat tenderization, pre-digestion of baby foods, fruit juice clarification, germination in breweries, and conversion of starch into glucose.

For More Insights Into The Market, Request A Sample Of This Report

https://www.factmr.com/connectus/sample?flag=S&rep_id=4483

Also, increasing inclination towards using pepsin for the production of curd and cheese from rennin is anticipated to propel the demand in the market for coming years.

On the basis of form, the power segment is projected to hold for the maximum share in the market, accounting for more than 69% of the sales in 2021. Primary factor favoring the growth in the segment are ease of storage, more applications, and logistics compared to liquid pepsin.

"Increasing research and development (R&D) activities of protein engineering and rising emphasis on the production of newer types of pepsin-based enzymes to catalyze reactions is expected to accelerate the growth in the market," says a Fact.MR analyst.

Key Takeaways from the Pepsin Market Analysis

  • The U.S. is estimated to dominate the market in North America, accounting owing to the increasing application of pepsin in the food & beverage industry.
  • With surging demand from cheese manufacturing in the U.K. and Germany, the market in Europe is projected to account for around 1/3rd of the global sales through 2031.
  • China is expected to emerge as the most lucrative market in Asia Pacific excluding Japan, projecting sales at a CAGR of 5.5% between 2021 and 2031.
  • India pepsin market is forecast to register a swift growth, expanding at a CAGR of 4.8% during the forecast period.
  • Based on end use sector, the pharmaceutical industry segment is anticipated to hold over 50% of the overall pepsin market share by 2031.

Key Drivers

  • Increasing application in flavoring food and functional beverages, vegetable processing, and preparation of fab fragments is propelling the demand for pepsin across the powder segment.
  • Rising demand for pepsin for manufacturing supplements and digestive syrup for heartburn, acid indigestion, and treatment of anemia is spurring the sales in the pharmaceutical industry.

Key Restraints

  • Adverse side-effects associated with the consumption of pepsin such as blockage of the stomach, gallstones, diarrhea, high amount of uric acid in the blood, and others are hampering the demand in the market.
  • High cost of pepsin and availability of low-cost substitutes such as chymosin for the production of cheese is hindering the sales across the food industry.

To gain in-depth insights on Pepsin Market, request methodology at

https://www.factmr.com/connectus/sample?flag=RM&rep_id=4483

Competitive Landscape

As per Fact.MR, the top tier manufacturers of pepsin in the global market are expected to account for more than 80% revenue share in 2021. Leading companies are emphasizing on improving the product quality and launch new products as per industry specific applications.

Some of the players are adopting strategies such as collaborations, partnerships, merger, and acquisition to expand that production capacity.

For instance,

  • In March 2021, Clara Foods, a San Francisco-based food technology company announced the launch of the first ever animal-free, animal pepsin for commercial use, which will be distributed by Ingredion, Clara's exclusive go-to-market partner for North America.

Some of the leading players in the market profiled by Fact.MR are:

  • A. Constantino & C.
  • Biolaxi Corporation
  • BIOZYM
  • Chongqing quanxinxiangsheng
  • Chongqing Jingkang Biotechnology
  • Deyang Sinozyme
  • Enzymology Research Center
  • Others

More Valuable Insights on Pepsin Market

Fact.MR, in its new report, offers a detailed analysis on the global pepsin market, analyzing forecast statistics for the assessment period 2021-2031. The study reveals growth projections in pepsin market with detailed segmentation:

  • By Product Form
    • Powdered Pepsin
    • Liquid Pepsin
  • By End-use Sector
    • Pepsin for Pharmaceuticals
    • Industrial Pepsin
    • Pepsin for Food and Feed
    • Others
  • By Grade Type
    • 1:3,000 Pepsin
    • 1:10,000 Pepsin
    • 1:15,000 Pepsin

Key Questions Covered in the Pepsin Market Report 

  • The market survey also highlights projected sales growth of the pepsin market between 2021 and 2031
  • The report offers insight into pepsin demand outlook for 2021-2031
  • Pepsin market share analysis of the key companies within the industry and coverage of strategies such as mergers & acquisitions, collaborations or partnerships, and others 
  • Pepsin market analysis identifies key growth drivers, restraints, and other forces impacting prevailing trends and evaluation of current market size and forecast and technological advancements within the industry 

Explore Fact.MR's Coverage on the Chemical & Materials Domain –

Pullulan Market Insights- Pullulan's growth can be attributed to its use in high-growing industries like food and pharmaceuticals. Furthermore, pullulan's penetration in the cosmetics business has boosted its sales throughout the years and is expected to continue on this path for the next ten years. Furthermore, due to the numerous benefits associated with skin, the usage of pullulan in the manufacture of skin care products is expected to gain traction. In addition, the usage of products in packaging materials has boosted their use in the food business.

Flavanols Market Forecast- Due to an increase in intake of flavanol-containing foods such as cocoa powder, green tea, and gala apples, flavanols are predicted to expand steadily over the projection period. In addition, the health benefits associated with flavanol consumption have raised demand over time. Changes in consumer lifestyles and growing demand for beauty and health supplements are predicted to promote flavanol usage throughout the forecast period. As the demand for convenience foods has expanded, the usage of flavanols in functional foods has increased.

Phenothiazine Market Scope- In the future decade, the demand for phenothiazine is expected to expand at a rapid pace. In the year 2020, the automotive industry's demand was muted, resulting in limited opportunities. However, phenothiazine sales from food and medicinal applications will continue to provide exclusive drive for the next decade. Several elements that stimulate the evolution of phenothiazine are heavily stimulated. Its widespread use in medical applications has given the sector a major boost. The market is also being pushed by a variety of demand notes from end-use sectors such as mining and personal care.

About Fact.MR

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range – from automotive & industry 4.0 to chemical and materials, technology to even the most niche categories. 80% of Fortune 1000's trust us in critical decision making.

MarketNgage is powered by Fact.MR – our Unified Intelligence Engine, a revolutionary Market Research Subscription platform with a flexible pricing to suit your needs.

You can access all our chemical and materials research reports by signing up with MarketNgage's Market Research Subscription with FREE credits. MarketNgage is powered by Fact.MR – A Fully integrated research solution for seamless single-window access Widest coverage on emerging markets, nascent products, and disruptive technologies.

Contact:

Mahendra Singh
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com

Logo: https://mma.prnewswire.com/media/713666/FactMR_Logo.jpg

Modal title

Also from this source

Bisabolene Market is Forecasted to Reach US$ 4.6 Million by 2034, Expanding at a CAGR of 3.9% | Fact.MR Report

According to a new research report published by Fact.MR, the global Bisabolene Market was valued at US$ 3 million in 2023 and has been forecasted to...

Hyaluronic Acid Raw Material Market is projected to grow at a CAGR of 5.2%, Reaching a value of $11.7 billion by 2034 | Fact.MR Report

The global Hyaluronic Acid Raw Material Market has been valued at US$ 7.05 billion in 2024, as stated in the recently updated industry analysis by...

More Releases From This Source

Explore

Medical Pharmaceuticals

Medical Pharmaceuticals

Health Care & Hospitals

Health Care & Hospitals

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.